Watching complex kidney cysts with regular scans
Part of Kidney & urinary clinical trials.
This study monitors people who have complex kidney cysts to see how they should be followed over time and whether it helps guide treatment. You may get regular imaging (scans), and you’ll be asked to complete questionnaires in English or French.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a kidney cyst labeled Bosniak III or IV (a specific scan-based category).
- The cyst is within size limits, and the solid/nodular part is small.
- Your diagnosis is new (made within the last 12 months).
- You are not having symptoms from the cyst right now, and your doctor feels you can have surgery if needed.
- You can do regular follow-up scans (including contrast dye if safe) and answer questionnaires in English or French.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special PET scan that may help doctors see if a complex kidney cyst is cancerous before surgery. It is for people who are already scheduled to have surgery to remove a kidney mass.
This trial compares two approaches for people with a kidney cyst that might be cancer: removing it with surgery, or keeping an eye on it with regular scans. It aims to see which option is better for long-term health.
This study tests whether closely monitoring small kidney tumors (less than 4 cm) with regular imaging is a safe and effective option for people who cannot or choose not to have immediate treatment. It involves a biopsy at the start to confirm the tumor type.
This study follows people with small, solid kidney tumors using active surveillance (regular monitoring) rather than immediate surgery or treatment. It may help you understand whether careful watching is a safe option for certain early kidney tumors.
This trial tests a new PET scan (a special imaging test) to better grade kidney cancer before surgery. The goal is to see if this scan can help doctors understand how aggressive the cancer is, so they can plan the best treatment for you.
This trial compares two approaches for people with slow-growing, metastatic clear cell kidney cancer: taking a daily pill (belzutifan) or monitoring the cancer closely without treatment. The goal is to see if starting treatment early can help control the cancer longer than waiting.
Hear when a new Complex Renal Cyst trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.